Sana Biotechnology (NASDAQ:SANA) Bolsa, Quote.MetaTitle.unusual-options

Sana Biotechnology

Sana Biotechnology Inc

Sanara MedTech Inc

SANAI HEALTH IND GROUP CO by SANAI HEALTH IND GROUP CO LTD.

Sanarco Funds Inc

Sanatana Resources Inc

Arbutus Biopharma Corporation - Common Stock

Arbutus Biopharma

AnaptysBio

BridgeBio Oncology Therapeutics, Inc. - Common Stock

BridgeBio Oncology

Biohaven

CureVac

Day One Biopharmaceuticals, Inc. - Common Stock

Day One Biopharmaceutical

Immatics

Inhibrx Biosciences

Iovance Biotherapeutics, Inc. - Common Stock

Iovance Biotherapeutics

Kodiak Sciences

Kura Oncology

MiMedx Group

Nanobiotix

Nurix Therapeutics

Novavax

Oric Pharmaceuticals, Inc. - Common Stock

ORIC Pharmaceuticals

Pharming Group N.V. - ADS, each representing 10 ordinary shares

Pharming

Palvella Therapeutics, Inc. - Common Stock

Palvella Therapeutics

Relay Therapeutics

Rezolute

ARS Pharmaceuticals

Tango Therapeutics

Taysha Gene Therapies, Inc. - Common Stock

Taysha Gene Therapies

UroGen Pharma

Xencor

Sana Biotechnology (SANA) Previsión

Noticias

Beneficios

Opciones

Calificaciones de analistas

Operaciones de insiders

Interés en corto

Informe de acciones

Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.

Comments

Sana Biotechnology Opciones Inusuales

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL